AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30994576 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal 10 μg estradiol tablet plus placebo gel (n = 102)
Number of subjects: 302
Study 30994576 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo tablet plus vaginal moisturizer (n = 100)
Number of subjects: 302
Study 30994576 — intervention group
Group type: COMPARATOR
Intervention: Dual placebo (n = 100)
Number of subjects: 302
Study 28341129 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand washing with alcohol gel only up to elbows (Group A)
Number of subjects: 5
Study 28341129 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand washing with soap up to elbows, sterile towel to dry, followed by alcohol gel (Group B)
Number of subjects: 5
Study 28341129 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand washing with soap up to elbows, non‐sterile towel to dry, followed by alcohol gel (Group C)
Number of subjects: 5
Study 28341129 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand washing with soap up to elbows, non‐sterile towel to dry (Group D)
Number of subjects: 5
Study 28341129 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand washing with soap up to elbows, sterile towel to dry (Group E)
Number of subjects: 5
Study 26923921 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogel contact lens wear for 8 hours
Number of subjects: 10
Study 26923921 — intervention group
Group type: COMPARATOR
Intervention: Control (non-lens-wearing eye)
Number of subjects: 10
Study 24418055 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-384 10 mg once daily
Number of subjects: 267
Study 24418055 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-384 50 mg once daily
Number of subjects: 267
Study 24418055 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 10 mg once daily
Number of subjects: 267
Study 24418055 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study 22048324 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (4.25 mmol L(‐1))
Number of subjects: 8
Study 22048324 — intervention group
Group type: EXPERIMENTAL
Intervention: L-glutamine (45 mmol L(‐1))
Number of subjects: 8
Study 22048324 — intervention group
Group type: COMPARATOR
Intervention: Glucose only
Number of subjects: 8
Study 22048324 — intervention group
Group type: COMPARATOR
Intervention: No glucose
Number of subjects: 8
Study 19250060 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide 20 microg/day
Number of subjects: 0
Study 19250060 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17488518 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m2 d1 and cisplatin 75 mg/m2 d1, q 3 weeks
Number of subjects: 0
Study 17488518 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine and cisplatin regimen
Number of subjects: 0
Study 17488518 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed and cisplatin
Number of subjects: 0
Study 17488518 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine and cisplatin
Number of subjects: 0
Study 15086477 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (400 IU/day)
Number of subjects: 993
Study 15086477 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 993
Study 12127641 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg orally followed by misoprostol 0.8 mg orally or vaginally 36-48 hours later
Number of subjects: 123
Study 9667273 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg methylphenidate twice daily
Number of subjects: 30
Study 9667273 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg methylphenidate twice daily
Number of subjects: 30
Study 9667273 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg methylphenidate twice daily
Number of subjects: 30
Study 9667273 — intervention group
Group type: EXPERIMENTAL
Intervention: methylphenidate treatment
Number of subjects: 30
Study 8137524 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg cetrorelix
Number of subjects: 16
Study 8137524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 8137524 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg cetrorelix
Number of subjects: 16
Study 8137524 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg cetrorelix
Number of subjects: 16
Study 2551084 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (visited by health visitors post-discharge)
Number of subjects: 135
Study 2551084 — intervention group
Group type: COMPARATOR
Intervention: Control group (received usual offers of assistance)
Number of subjects: 135
Study 2551084 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 135
Study 2551084 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 135
Study 1042713 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory information group
Number of subjects: 84
Study 1042713 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedure information group
Number of subjects: 84
Study 1042713 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84
Study 1042713 — intervention group
Group type: EXPERIMENTAL
Intervention: No pre-fear group
Number of subjects: 84
Study 1042713 — intervention group
Group type: EXPERIMENTAL
Intervention: Some pre-fear group
Number of subjects: 84
Study 29787478 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance training program with elastic bands (12 months, six exercises, three sets × 10 repetitions)
Number of subjects: 38
Study 29787478 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 38
Study 27997669 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic air exchange (DAE) prosthesis
Number of subjects: 5
Study 27997669 — intervention group
Group type: COMPARATOR
Intervention: Total surface bearing suction socket (Suction) prosthesis
Number of subjects: 5
Study 27997669 — intervention group
Group type: EXPERIMENTAL
Intervention: Both prostheses
Number of subjects: 5
Study 27997669 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire results
Number of subjects: 5
Study 25518578 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without depressive symptoms
Number of subjects: 100
Study 25518578 — intervention group
Group type: COMPARATOR
Intervention: Patients with mild depressive symptoms (40% of patients)
Number of subjects: 100
Study 22891232 — intervention group
Group type: EXPERIMENTAL
Intervention: FSV/TPGS preparation coadministered with additional vitamin K
Number of subjects: 92
Study 22891232 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 92
Study 22891232 — intervention group
Group type: EXPERIMENTAL
Intervention: FSV/TPGS preparation
Number of subjects: 92
Study 20543018 — intervention group
Group type: EXPERIMENTAL
Intervention: On-call physical therapy
Number of subjects: 38
Study 20543018 — intervention group
Group type: COMPARATOR
Intervention: Regular physical therapy (Control)
Number of subjects: 38
Study 17720303 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin treatment
Number of subjects: 8
Study 17720303 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 8
Study 17720303 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate atherosclerosis (no specific treatment mentioned)
Number of subjects: 8
Study 15925748 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential amino acids (EAA) for 4 months
Number of subjects: 25
Study 15925748 — intervention group
Group type: COMPARATOR
Intervention: L-NMMA (intra-arterial infusion of 4 micromol/min)
Number of subjects: 25
Study 12885701 — intervention group
Group type: EXPERIMENTAL
Intervention: Bread and cookies rich in beta-glucan (5.9 g/day)
Number of subjects: 48
Study 12885701 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice containing beta-glucan (5 g/day)
Number of subjects: 48
Study 12885701 — intervention group
Group type: COMPARATOR
Intervention: Control bread and cookies rich in wheat fiber
Number of subjects: 48
Study 11099445 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with Parkinson's disease
Number of subjects: 25
Study 11099445 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 25
Study 8993769 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer factor (TF) treatment
Number of subjects: 99
Study 8993769 — intervention group
Group type: COMPARATOR
Intervention: Non-treated controls
Number of subjects: 99
Study 1482265 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors (CEI)
Number of subjects: 236
Study 1482265 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium antagonists (CA)
Number of subjects: 236
Study 3912334 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg i.v. indoprofen
Number of subjects: 40
Study 3912334 — intervention group
Group type: COMPARATOR
Intervention: 10 mg i.m. morphine hydrochloride
Number of subjects: 40
Study 31679509 — intervention group
Group type: COMPARATOR
Intervention: Intermittent boluses (1.5 mcg/Kg phenylephrine)
Number of subjects: 217
Study 31679509 — intervention group
Group type: COMPARATOR
Intervention: Fixed on-and-off infusion (0.75 mcg/Kg/min)
Number of subjects: 217
Study 31679509 — intervention group
Group type: COMPARATOR
Intervention: Variable infusion (0.75 mcg/Kg/min)
Number of subjects: 217
Study 30153993 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 64
Study 30153993 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril (subgroup with right ventricular restrictive physiology)
Number of subjects: 64
Study 30153993 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 27553010 — intervention group
Group type: EXPERIMENTAL
Intervention: Born to Move (BTM) intervention
Number of subjects: 139
Study 27553010 — intervention group
Group type: COMPARATOR
Intervention: Control (COM) group
Number of subjects: 139
Study 24907879 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq™ laryngoscope
Number of subjects: 132
Study 24907879 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 132
Study 22324055 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted Physical Activities (G1)
Number of subjects: 36
Study 22324055 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii Fit(®) (G2)
Number of subjects: 36
Study 22324055 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted Physical Activities + Wii Fit(®) (G3)
Number of subjects: 36
Study 22324055 — intervention group
Group type: COMPARATOR
Intervention: No training (G4)
Number of subjects: 36
Study 20678306 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate/formoterol 200/10 microg (MF/F)
Number of subjects: 781
Study 20678306 — intervention group
Group type: COMPARATOR
Intervention: Mometasone furoate 200 microg (MF)
Number of subjects: 781
Study 20678306 — intervention group
Group type: COMPARATOR
Intervention: Formoterol 10 microg (F)
Number of subjects: 781
Study 20678306 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 781
Study 19000211 — intervention group
Group type: EXPERIMENTAL
Intervention: Photographs of scenes interrupted by a 42‐ms or 250‐ms mask, 250 ms into viewing
Number of subjects: 0
Study 19000211 — intervention group
Group type: EXPERIMENTAL
Intervention: Photographs of scenes changed after interruption
Number of subjects: 0
Study 19000211 — intervention group
Group type: EXPERIMENTAL
Intervention: Interruption included a saccade
Number of subjects: 0
Study 15718305 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg/m² once every 3 weeks
Number of subjects: 51
Study 12212960 — intervention group
Group type: EXPERIMENTAL
Intervention: Cylinder O2
Number of subjects: 41
Study 12212960 — intervention group
Group type: COMPARATOR
Intervention: Cylinder air
Number of subjects: 41
Study 10340423 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal baclofen (50 microg bolus injection)
Number of subjects: 6
Study 8549019 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 4
Study 8549019 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 1662941 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 0
Study 1662941 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 0
Study 7102728 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (active medication)
Number of subjects: 10
Study 7102728 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 10
Study 31039763 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow-derived mesenchymal cells (BM-MSCs) mixed with platelet-rich plasma (PRP), thrombin, and calcium, plus β-tricalcium phosphate (β-TCP) for bone regeneration.
Number of subjects: 83
Study 31039763 — intervention group
Group type: EXPERIMENTAL
Intervention: BM-MSCs treatment
Number of subjects: 83
Study 31039763 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 83
Study 27669653 — intervention group
Group type: COMPARATOR
Intervention: Outpatient surgery
Number of subjects: 7767
Study 27669653 — intervention group
Group type: COMPARATOR
Intervention: Inpatient surgery
Number of subjects: 7767
Study 27669653 — intervention group
Group type: COMPARATOR
Intervention: Gynecologists
Number of subjects: 7767
Study 27669653 — intervention group
Group type: COMPARATOR
Intervention: Resident participation
Number of subjects: 7767
Study 26669546 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate implant placement (25 patients)
Number of subjects: 50
Study 26669546 — intervention group
Group type: COMPARATOR
Intervention: Delayed implant placement (25 patients)
Number of subjects: 50
Study 26669546 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate group (25 patients)
Number of subjects: 50
Study 26669546 — intervention group
Group type: COMPARATOR
Intervention: Delayed group (23 patients)
Number of subjects: 50
Study 24932599 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate counting
Number of subjects: 84
Study 24932599 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 84
Study 22947443 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation in addition to chest physiotherapy (8 weeks)
Number of subjects: 30
Study 22947443 — intervention group
Group type: COMPARATOR
Intervention: Chest physiotherapy (8 weeks)
Number of subjects: 30
Study 19716961 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast 500 microg once a day for 24 weeks with salmeterol
Number of subjects: 837
Study 19716961 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast 500 microg once a day for 24 weeks with tiotropium
Number of subjects: 837
Study 19716961 — intervention group
Group type: COMPARATOR
Intervention: Roflumilast
Number of subjects: 837
Study 17449929 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced intensity conditioning (fludarabine/melphalan, fludarabine/cyclophosphamide)
Number of subjects: 75
Study 17449929 — intervention group
Group type: COMPARATOR
Intervention: Myeloablative conditioning (busulfan/cyclophosphamide)
Number of subjects: 75
Study 17449929 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced intensity conditioning
Number of subjects: 75
Study 17449929 — intervention group
Group type: COMPARATOR
Intervention: Myeloablative conditioning
Number of subjects: 75
Study 15229004 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm deliveries after spontaneous initiation of labor without maternal complications
Number of subjects: 3304
Study 15229004 — intervention group
Group type: EXPERIMENTAL
Intervention: Medically indicated preterm deliveries with maternal obstetric and medical complications
Number of subjects: 3304
Study 15229004 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm deliveries after prelabor spontaneous rupture of amniotic membranes (PROM) with complications
Number of subjects: 3304
Study 15229004 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm deliveries with obstetric and medical complications
Number of subjects: 3304
Study 15229004 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical presentation (PROM or medically indicated)
Number of subjects: 3304
Study 12195603 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 micro g once daily
Number of subjects: 0
Study 12195603 — intervention group
Group type: COMPARATOR
Intervention: Ipratropium bromide 40 micro g four times daily
Number of subjects: 0
Study 9578047 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg midazolam (MDL) in 2 ml peppermint-flavored fluid
Number of subjects: 10
Study 9578047 — intervention group
Group type: COMPARATOR
Intervention: Placebo (peppermint-flavored fluid)
Number of subjects: 10
Study 10522780 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release of subgingivally delivered doxycycline hyclate in a polylactic acid based polymer gel
Number of subjects: 358
Study 10522780 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing alone (SRP)
Number of subjects: 358
Study 2072698 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraluminal radiotherapy (ILRT) plus concurrent 5-fluorouracil (5-FU) infusion
Number of subjects: 50
Study 2072698 — intervention group
Group type: COMPARATOR
Intervention: Intraluminal radiotherapy (ILRT) alone
Number of subjects: 50
Study 6849205 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg metronidazole intravenously every 6 hours for three doses
Number of subjects: 144
Study 6849205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 30730785 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg of folic acid for 16 weeks
Number of subjects: 80
Study 30730785 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 16 weeks
Number of subjects: 80
Study 29573207 — intervention group
Group type: EXPERIMENTAL
Intervention: Rolontis 270 μg/kg
Number of subjects: 0
Study 29573207 — intervention group
Group type: EXPERIMENTAL
Intervention: Rolontis 135 μg/kg
Number of subjects: 0
Study 29573207 — intervention group
Group type: EXPERIMENTAL
Intervention: Rolontis 45 μg/kg
Number of subjects: 0
Study 29573207 — intervention group
Group type: COMPARATOR
Intervention: Pegfilgrastim 6 mg
Number of subjects: 0
Study 26853325 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (12 mg/day for 3 weeks followed by tapering)
Number of subjects: 20
Study 26853325 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 26853325 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 20
Study 25314962 — intervention group
Group type: EXPERIMENTAL
Intervention: Communities First regeneration scheme
Number of subjects: 4226
Study 23304687 — intervention group
Group type: EXPERIMENTAL
Intervention: High insertion torque (>80 Ncm)
Number of subjects: 50
Study 23304687 — intervention group
Group type: COMPARATOR
Intervention: Medium insertion torque (25 to 35 Ncm)
Number of subjects: 50
Study 23304687 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 19864114 — intervention group
Group type: EXPERIMENTAL
Intervention: First-generation antipsychotic (perphenazine)
Number of subjects: 623
Study 19864114 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotic (quetiapine)
Number of subjects: 623
Study 18297829 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-curing mode of LED curing light (Mini LED)
Number of subjects: 30
Study 18297829 — intervention group
Group type: COMPARATOR
Intervention: Step-curing mode of LED curing light
Number of subjects: 30
Study 15712594 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavanol-containing milk chocolate (FCMC)
Number of subjects: 28
Study 15712594 — intervention group
Group type: COMPARATOR
Intervention: Cocoa butter chocolate (CBC)
Number of subjects: 28
Study 11896327 — intervention group
Group type: EXPERIMENTAL
Intervention: PEN110 treatment (pathogen-inactivated RBCs)
Number of subjects: 12
Study 11896327 — intervention group
Group type: COMPARATOR
Intervention: Control units (additive system control)
Number of subjects: 12
Study 11896327 — intervention group
Group type: EXPERIMENTAL
Intervention: PEN110 treatment
Number of subjects: 12
Study 9008372 — intervention group
Group type: EXPERIMENTAL
Intervention: High self-esteem (manipulated in Experiment 1; dispositional in Experiment 2)
Number of subjects: 0
Study 9008372 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate self-esteem
Number of subjects: 0
Study 9008372 — intervention group
Group type: EXPERIMENTAL
Intervention: High self-esteem
Number of subjects: 0
Study 8314495 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon in acute hepatitis C
Number of subjects: 0
Study 8314495 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 3571503 — intervention group
Group type: EXPERIMENTAL
Intervention: Subliminal presentation of positive emotional concepts
Number of subjects: 36
Study 3571503 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraliminal presentation of positive emotional concepts
Number of subjects: 36
Study 3571503 — intervention group
Group type: COMPARATOR
Intervention: Subliminal presentation of negative emotional concepts
Number of subjects: 36
Study 30326888 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive diabetes risk prediction model (German Diabetes Risk Score) used during routine health check.
Number of subjects: 300
Study 30326888 — intervention group
Group type: COMPARATOR
Intervention: Routine health check 'Check-up 35' (control group).
Number of subjects: 300
Study 27650139 — intervention group
Group type: EXPERIMENTAL
Intervention: Lip training with 200 or 400 g of bottled water in the oral vestibule
Number of subjects: 66
Study 25183507 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of rosemary essential oil for three minutes
Number of subjects: 33
Study 25183507 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of lavender essential oil for three minutes
Number of subjects: 33
Study 25183507 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of eucalyptus essential oil for three minutes
Number of subjects: 33
Study 25183507 — intervention group
Group type: COMPARATOR
Intervention: Control for cardiovascular variables (HR and BP)
Number of subjects: 33
Study 22613015 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention A (written information - leaflet describing correct inhalation techniques)
Number of subjects: 495